Cidara Therapeutics, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Cidara Therapeutics, Inc. (CDTX) is 4.62

According to Cidara Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.62. This represents a change of -36.70% compared to the average of 7.30 of the last 4 quarters.

Cidara Therapeutics, Inc. (CDTX) Historical Current Ratio (quarterly & annually)

How has CDTX Current Ratio performed in the past?

The mean historical Current Ratio of Cidara Therapeutics, Inc. over the last ten years is 5.23. The current 4.62 Current Ratio has changed 8.74% with respect to the historical average. Over the past ten years (40 quarters), CDTX's Current Ratio was at its highest in in the March 2016 quarter at 24.04. The Current Ratio was at its lowest in in the March 2024 quarter at 0.72.

Cidara Therapeutics, Inc. (CDTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Cidara Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cidara Therapeutics, Inc. (CDTX) Average Current Ratio

How has CDTX Current Ratio performed in the past?

The current Current Ratio of Cidara Therapeutics, Inc. (CDTX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Cidara Therapeutics, Inc. (CDTX) Current Ratio vs. Peers

How is CDTX’s Current Ratio compared to its peers?

Cidara Therapeutics, Inc.’s Current Ratio is less than Mineralys Therapeutics, Inc. (44.33), greater than Adaptive Biotechnologies Corporation (3.35), less than Scholar Rock Holding Corporation (8.64), less than IDEAYA Biosciences, Inc. (10.74), greater than Zai Lab Limited (2.40), less than Beam Therapeutics Inc. (16.99), less than Catalyst Pharmaceuticals, Inc. (7.10), greater than Legend Biotech Corporation (2.13), less than Disc Medicine, Inc. (24.00), less than Agios Pharmaceuticals, Inc. (14.19),

Build a custom stock screener for Cidara Therapeutics, Inc. (CDTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cidara Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cidara Therapeutics, Inc. (CDTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cidara Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.